|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
价值评估 |
盈利(现时/预测)
-0.39/0.53
|
企业价值
2.88B
|
资产负债 |
每股账面净值
6.56
|
现金流量 |
现金流量率
0.03
|
损益表 |
收益
354.34M
|
每股收益
2.19
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟:2024/05/20 09:06 EDT
同行比较之报价最少15分钟延迟
业务概览
|
|||
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region. |